Abstract

BackgroundThis study aimed to determine the therapeutic effects of highly active anti-retroviral therapy (HAART) on the clinical presentations of HIV related oral lesions (HIV-ROLs) in an adult Nigerian population.MethodsA 5 month prospective study on HAART naïve HIV positive adults recruited into the HAART program of an AIDS referral centre. HIV-ROLs were diagnosed clinically by the EEC Clearinghouse on oral problems related to HIV infection. Baseline clinical features of HIV-ROLs was documented by clinical photographs using SONY® 5.2 M Cybershot digital camera. Post HAART monthly review was conducted using clinical photographs.ResultsA total of 142 patients were seen. Age range was 19 - 75 years. Mean age was 35.6 ± 10.5 (SD). Eighty (56.3%) were females. Prevalence of HIV-ROLs was 43.7%. Oral candidiasis (22.4%) was the most prevalent HIV-ROL. 114 (83.2%) patients had clinical AIDS at presentation (CDC 1993). 89.4% were placed on Tenofovir/Emtricitabine +`Nevirapine, 9.9% on Tenofovir/Emtricitabine + Efavirenz. There was strong decline in the clinical features of oral candidiasis from a month of commencing HAART. Oral hairy leukoplakia was slow in responding to HAART. Parotid gland enlargement, melanotic hyperpigmentation and Kaposi's sarcoma were more persistent and had slower response to HAART. There was no clinical change noticed in linear gingival erythema.ConclusionHAART has different clinical effects on HIV related oral lesions depending on the size, duration of treatment and etiology of the lesions. HIV-ROLs of fungal origin have the fastest response to HAART. These lesions alongside immunologic parameters can be used as indicators of success or failure of antiretroviral therapy.

Highlights

  • This study aimed to determine the therapeutic effects of highly active anti-retroviral therapy (HAART) on the clinical presentations of human immunodeficiency virus (HIV) related oral lesions (HIV-ROLs) in an adult Nigerian population

  • In recent years, the management of human immunodeficiency virus (HIV) positive individuals has been based on highly active antiretroviral therapy (HAART) comprising a combination of nucleoside analogue reverse transcriptase inhibitors and at least one protease inhibitor and/or one non-nucleoside analogue reverse transcriptase inhibitor [1,2]

  • Since the introduction of HAART in the mid1990s, it has been accompanied by a reduction in the frequency of many of the secondary events caused by HIV infection, including some oral lesions [3,4,5]

Read more

Summary

Introduction

This study aimed to determine the therapeutic effects of highly active anti-retroviral therapy (HAART) on the clinical presentations of HIV related oral lesions (HIV-ROLs) in an adult Nigerian population. Oral manifestations of HIV infections are sometimes the first sign of the infection and often indicate its progression to AIDS. They have been considered of value as indicators of success or failure of antiretroviral therapy. It has been reported that HAART has a marked effect on the prevalence and clinical appearance on HIVrelated oral lesions [6]. These effects vary from review of the literatures

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call